ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633398 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633398; 2) Community: the network communities that were significantly associated with the response to NSC 633398; 3) Molecule: the relationships between components within communities and NSC 633398; 4) MDR: the compounds that were significantly associated with the NSC 633398.

NSC Compound Enrichment Correlation
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.00457614317494024 0.16383029
NSC 10848 Null 0.00479683626511385 -0.1082761
NSC 221266 Benzoic acid, 3,4-dichloro-, [1-[4-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, monohy 0.00479683626511385 0.37952052
NSC 243022 Cinerubin A hydrochloride 0.00479683626511385 0.36630737
NSC 244714 Benzoic acid, 3,5-dinitro-2-(1H-purin-6-ylthio)-, ethyl ester 0.00479683626511385 0.28389288
NSC 250682 Oridonin 0.00479683626511385 0.32296498
NSC 3088 Chlorambucil 0.00479683626511385 0.38434353
NSC 372944 Null 0.00479683626511385 0.36101975
NSC 600758 Null 0.00479683626511385 0.37498299
NSC 610459 Camptothecin Derivative 0.00479683626511385 0.20253213
Total:169  Current:39    [First] [Prev] [Next] [Last]